These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 22064914)
21. Reduction of some Pt(IV) complexes with biologically important sulfur-donor ligands. Jovanović S; Petrović B; Bugarčić ŽD; van Eldik R Dalton Trans; 2013 Jun; 42(24):8890-6. PubMed ID: 23657491 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of platinum-ethacrynic acid conjugates in the treatment of mesothelioma. Zanellato I; Bonarrigo I; Sardi M; Alessio M; Gabano E; Ravera M; Osella D ChemMedChem; 2011 Dec; 6(12):2287-93. PubMed ID: 22025407 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours. Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921 [TBL] [Abstract][Full Text] [Related]
24. NMR investigation of the spontaneous thermal- and/or photoinduced reduction of trans dihydroxido Pt(IV) derivatives. Petruzzella E; Margiotta N; Ravera M; Natile G Inorg Chem; 2013 Mar; 52(5):2393-403. PubMed ID: 23414056 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro. Kratochwil NA; Zabel M; Range KJ; Bednarski PJ J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447 [TBL] [Abstract][Full Text] [Related]
26. Photolysis of an iodoplatinum(IV) diamine complex to cytotoxic species by visible light. Kratochwil NA; Bednarski PJ; Mrozek H; Vogler A; Nagle JK Anticancer Drug Des; 1996 Mar; 11(2):155-71. PubMed ID: 8630187 [TBL] [Abstract][Full Text] [Related]
27. Oxidation of a guanine derivative coordinated to a Pt(IV) complex initiated by intermolecular nucleophilic attacks. Choi S; Personick ML; Bogart JA; Ryu D; Redman RM; Laryea-Walker E Dalton Trans; 2011 Mar; 40(12):2888-97. PubMed ID: 21318207 [TBL] [Abstract][Full Text] [Related]
28. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV). Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266 [TBL] [Abstract][Full Text] [Related]
30. cis-[Pt(II) (1R,2R-DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)], a water-soluble, oxalate-free and stable analogue of oxaliplatin: synthesis, characterization, and biological evaluations. Liu W; Ye Q; Jiang J; Lou L; Xu Y; Xie C; Xie M ChemMedChem; 2013 Sep; 8(9):1465-7. PubMed ID: 23825063 [No Abstract] [Full Text] [Related]
31. Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules. Bugarčić ŽD; Bogojeski J; Petrović B; Hochreuther S; van Eldik R Dalton Trans; 2012 Oct; 41(40):12329-45. PubMed ID: 22890549 [TBL] [Abstract][Full Text] [Related]
32. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation. Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543 [TBL] [Abstract][Full Text] [Related]
33. Hydrolysis process of the second generation platinum-based anticancer drug cis-amminedichlorocyclohexylamineplatinum(II). Zhu C; Raber J; Eriksson LA J Phys Chem B; 2005 Jun; 109(24):12195-205. PubMed ID: 16852504 [TBL] [Abstract][Full Text] [Related]
34. Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line. Mauldin SK; Gibbons G; Wyrick SD; Chaney SG Cancer Res; 1988 Sep; 48(18):5136-44. PubMed ID: 3409241 [TBL] [Abstract][Full Text] [Related]
35. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand. Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941 [TBL] [Abstract][Full Text] [Related]
36. Pt(II)-mediated nitrile-tetramethylguanidine coupling as a key step for a novel synthesis of 1,6-dihydro-1,3,5-dihydrotriazines. Gushchin PV; Bokach NA; Luzyanin KV; Nazarov AA; Haukka M; Kukushkin VY Inorg Chem; 2007 Mar; 46(5):1684-93. PubMed ID: 17266300 [TBL] [Abstract][Full Text] [Related]
37. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs. Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806 [TBL] [Abstract][Full Text] [Related]
38. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents. Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657 [TBL] [Abstract][Full Text] [Related]